Global Medical REIT, Inc. (NASDAQ:GMRE) – Equities research analysts at DA Davidson lifted their Q4 2017 earnings estimates for Global Medical REIT in a report issued on Monday. DA Davidson analyst B. Oxford now anticipates that the company will post earnings of $0.16 per share for the quarter, up from their previous estimate of $0.14. DA Davidson has a “Neutral” rating and a $10.00 price objective on the stock. DA Davidson also issued estimates for Global Medical REIT’s Q2 2018 earnings at $0.18 EPS, Q3 2018 earnings at $0.21 EPS, Q4 2018 earnings at $0.21 EPS, Q2 2019 earnings at $0.20 EPS, Q3 2019 earnings at $0.21 EPS and FY2019 earnings at $0.82 EPS.

A number of other brokerages also recently weighed in on GMRE. Zacks Investment Research downgraded shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Tuesday, November 7th. FBR & Co reissued a “buy” rating and set a $10.50 target price (up previously from $10.00) on shares of Global Medical REIT in a research note on Monday, September 18th. B. Riley reissued a “buy” rating on shares of Global Medical REIT in a research note on Wednesday, November 1st. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $12.00 target price on shares of Global Medical REIT in a research note on Friday, September 1st. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $10.60.

COPYRIGHT VIOLATION NOTICE: “Global Medical REIT, Inc. (GMRE) Forecasted to Earn Q4 2017 Earnings of $0.16 Per Share” was published by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/11/14/global-medical-reit-inc-gmre-forecasted-to-earn-q4-2017-earnings-of-0-16-per-share.html.

Global Medical REIT (NASDAQ:GMRE) opened at $9.22 on Tuesday. Global Medical REIT has a 52 week low of $7.04 and a 52 week high of $10.25.

A number of institutional investors and hedge funds have recently bought and sold shares of GMRE. Neuberger Berman Group LLC increased its stake in Global Medical REIT by 303.0% in the second quarter. Neuberger Berman Group LLC now owns 266,815 shares of the company’s stock valued at $2,385,000 after purchasing an additional 200,606 shares in the last quarter. Stifel Financial Corp bought a new stake in Global Medical REIT in the third quarter valued at $1,007,000. Manning & Napier Advisors LLC increased its stake in Global Medical REIT by 17.3% in the second quarter. Manning & Napier Advisors LLC now owns 609,735 shares of the company’s stock valued at $5,449,000 after purchasing an additional 89,975 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in Global Medical REIT in the second quarter valued at $754,000. Finally, State of Wisconsin Investment Board increased its stake in Global Medical REIT by 20.0% in the second quarter. State of Wisconsin Investment Board now owns 433,050 shares of the company’s stock valued at $3,871,000 after purchasing an additional 72,100 shares in the last quarter.

Global Medical REIT Company Profile

Earnings History and Estimates for Global Medical REIT (NASDAQ:GMRE)

Receive News & Ratings for Global Medical REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.